Chemical activators of TEX16 can initiate a sequence of events leading to its activation through various cellular signaling pathways. Forskolin, a well-known adenylyl cyclase activator, directly increases the intracellular concentration of cyclic AMP (cAMP), which in turn activates protein kinase A (PKA). The activation of PKA is pivotal as it can phosphorylate a multitude of target proteins, including TEX16, thereby activating it. This pathway is not exclusive to Forskolin, as other chemicals such as Isoproterenol, Salbutamol, Terbutaline, and Dobutamine also function through beta-adrenergic receptors, which similarly result in elevated cAMP levels and subsequent activation of PKA. Each of these chemicals, by binding to their respective receptors, initiates a cascade that culminates in the activation of TEX16 via phosphorylation by PKA.
In parallel, IBMX, Rolipram, and Cholera Toxin also increase cAMP levels but through different mechanisms. IBMX and Rolipram act by inhibiting phosphodiesterases, which normally degrade cAMP, thereby preventing the decrease in its intracellular levels. This inhibition ensures that PKA remains active for a longer period, providing an extended window for TEX16 activation. Cholera Toxin, meanwhile, directly targets the Gs alpha subunit, leading to a sustained activation of adenylyl cyclase and a continuous production of cAMP, thus providing a persistent activation signal for PKA. Furthermore, endogenous agonists such as Epinephrine, PGE1, PGE2, and Glucagon also play roles in upregulating cAMP and activating PKA. Epinephrine binds to adrenergic receptors, PGE1 and PGE2 bind to E-prostanoid receptors, and Glucagon interacts with its receptor; each of these interactions result in the activation of adenylyl cyclase, increased cAMP, and PKA activation, which can lead to the phosphorylation and activation of TEX16. This collection of chemicals, through their distinct interactions with cellular receptors and enzymes, converges on a common pathway that ensures the activation of PKA and the subsequent phosphorylation and activation of TEX16.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX inhibits phosphodiesterases, leading to an increase in cAMP by preventing its degradation. Elevated cAMP activates PKA, which may result in the phosphorylation and activation of TEX16. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine binds to adrenergic receptors, initiating a signaling cascade that increases cAMP and activates PKA. PKA can then phosphorylate and activate TEX16 as part of the response. | ||||||
PGE1 (Prostaglandin E1) | 745-65-3 | sc-201223 sc-201223A | 1 mg 10 mg | $31.00 $145.00 | 16 | |
PGE1 binds to E-prostanoid receptors, which can increase intracellular cAMP and activate PKA, potentially leading to the activation of TEX16 through phosphorylation. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
PGE2 interacts with its E-prostanoid receptors, causing an increase in cAMP, which activates PKA. PKA may then phosphorylate TEX16, leading to its activation. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol activates beta-adrenergic receptors, increasing cAMP, and thereby activating PKA. PKA can phosphorylate TEX16, leading to its activation. | ||||||
Salbutamol | 18559-94-9 | sc-253527 sc-253527A | 25 mg 50 mg | $94.00 $141.00 | ||
Salbutamol, a beta-2 adrenergic agonist, increases cAMP levels, leading to PKA activation. PKA can then activate TEX16 through phosphorylation. | ||||||
Terbutaline Hemisulfate | 23031-32-5 | sc-204911 sc-204911A | 1 g 5 g | $92.00 $378.00 | 2 | |
Terbutaline activates beta-2 adrenergic receptors, which increases cAMP and activates PKA, potentially leading to the activation of TEX16 by phosphorylation. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram inhibits phosphodiesterase 4, causing an increase in cAMP which activates PKA. PKA can then phosphorylate and activate TEX16. | ||||||
Dobutamine | 34368-04-2 | sc-507555 | 100 mg | $295.00 | ||
Dobutamine activates beta-1 adrenergic receptors, which leads to an increase in cAMP and PKA activation. PKA-mediated phosphorylation could activate TEX16. | ||||||